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MINIREVIEW

Should I Stay or Should I Go?
Eukaryotic Translation Initiation
Factors 1 and 1A Control Start
Codon Recognition*
Published, JBC Papers in Press, June 30, 2008, DOI 10.1074/jbc.R800031200

Sarah F. Mitchell and Jon R. Lorsch1
From the Department of Biophysics and Biophysical Chemistry, Johns
Hopkins University School of Medicine, Baltimore, Maryland 21205

Start codon selection is a key step in translation initiation as it
sets the reading frame for decoding. Two eukaryotic initiation
factors, eIF1 and eIF1A, are key actors in this process. Recent
work has elucidated many details of the mechanisms these factors use to control start site selection. eIF1 prevents the irreversible GTP hydrolysis that commits the ribosome to initiation at a
particular codon. eIF1A both promotes and inhibits commitment through the competing influences of its two unstructured
termini. Both factors perform their tasks through a variety of
interactions with other components of the initiation machinery,
in many cases mediated by the unstructured regions of the two
proteins.

Translation initiation begins the final major step in gene
expression and is a highly regulated process. Initiation entails
the formation of a functional ribosomal complex (80 S in
eukaryotes) with an initiator methionyl-tRNA (Met-tRNAi)
bound in the P-site, its anticodon base-paired to the start codon
of an mRNA, poised to begin peptide synthesis. Formation of
the initiation complex is promoted and regulated by a number
of non-ribosomal proteins called initiation factors (IFs,2 or for
eukaryotes, eIFs).
Many details of eukaryotic translation initiation have been
elucidated over the last three decades using genetic, biochemical, and structural techniques. As this review focuses on the
roles of eIF1 and eIF1A in start site selection, only a brief overview of the entire process will be given (Fig. 1). For a more
complete description, see one of several recent comprehensive
reviews (1–3). Met-tRNAi is delivered to the P-site of the small
(40 S) ribosomal subunit in the form of a ternary complex (TC)
including GTP and the trimeric GTPase eIF2, forming the 43 S
pre-initiation complex (PIC) in a process promoted by eIF1,
eIF1A, and eIF3. The 43 S PIC then binds the 5⬘-end of an
mRNA with the help of eIF3, eIF4A, eIF4B, and eIF4F, creating
the 48 S PIC. The mRNA is thought to be circularized through
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the interactions of PABP with the 3⬘-poly(A) tail of the mRNA
and the eIF4F 5⬘-cap-binding complex. The complex is then
believed to scan along the mRNA in search of the start codon in
an ATP-dependent process. During this search, eIF2 partially
hydrolyzes its bound GTP with the help of the GTPase-activating factor eIF5. Prior to start codon recognition, the resultant
phosphate ion is not released, producing GTP- and GDP䡠Pibound states of the factor, possibly in equilibrium (4). Upon
identification of the start codon, the phosphate is released,
making GTP hydrolysis irreversible and committing the complex
to proceeding with initiation at that site on the mRNA. After
eIF2䡠GDP release, the 60 S subunit can join the 40 S subunit with
the help of a second GTPase, eIF5B. When eIF5B䡠GDP dissociates
after subunit joining, the initiation complex is complete and
ready to begin the elongation phase of translation.
In eukaryotic cells, at least twelve factors, composed of over
two dozen polypeptides, are required for initiation complex
formation. The same end is achieved by three IFs in bacterial
cells. Why is there such a discrepancy between domains for
accomplishing virtually the same goal? One important mechanistic difference between initiation in bacteria and eukaryotes is
the method of start site selection. Bacterial mRNAs contain a
Shine-Dalgarno sequence that base pairs to the 16 S rRNA,
holding the mRNA in place so that the start codon is recognized. No such complementary sequences are found in eukaryotic messenger and ribosomal RNAs. Instead, a PIC searches
the 5⬘-untranslated region of the mRNA for the start codon,
usually the 5⬘-most AUG. Consensus sequences have been
found in a variety of eukaryotic organisms (5–7) but have not
been shown to base pair to rRNA. Rather, the scanning PIC
responds to a set of less obvious and less well understood signals
that occur upon start codon recognition. The importance of heeding such signals is obvious. Initiation at an incorrect codon will
most likely make a completely miscoded protein, wasting the cell’s
valuable resources and creating a potentially toxic peptide.
Evolution has solved the problem of start codon recognition
in eukaryotes with a rather baroque mechanism. Start site recognition is not the job of a single factor but is instead achieved
through the cooperative actions of many. This, of course, makes
the problem of understanding how the system works that much
more challenging. Despite these difficulties, great progress has
been made in understanding the roles of individual factors and
the mechanisms of their action in start site selection. The picture that has developed over the last few years is one of a constantly changing PIC in which factors interact with a shifting
array of different partners as they progress through the steps of
initiation. Even the smallest of proteins, 12-kDa eIF1 and
17-kDa eIF1A, interact with a number of other components
throughout the process, reaching out their unstructured termini (Fig. 2) to communicate. Between them, these two factors
participate in factor recruitment, scanning of the 5⬘-untranslated region, restraining and promoting GTP hydrolysis and Pi
release, controlling key conformational rearrangements of the
complex, and subunit joining. Recent work has made it clear
that the roles of eIF1 and eIF1A in start codon recognition are
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 1. Model of eukaryotic translation initiation. The first step of translation initiation is the binding of a absence of eIF1, the rate of eIF5TC composed of eIF2, GTP, and Met-tRNAiMet to the 40 S ribosomal subunit forming the 43 S PIC. TC may bind
the 40 S subunit as part of the MFC along with eIF1, eIF5, and eIF3. eIF1A also binds and facilitates MFC stimulated GTP hydrolysis is the
recruitment. The N- and C-terminal tails of eIF1 and eIF1A are represented in green and pink, respectively. same, regardless of the presence of
Although their locations in the complex are not known, some proposed interactions are shown here. The PIC mRNA on the PIC (20). The addithen binds mRNA with the help of eIF3, the eIF4F complex, eIF4B, and PABP. For clarity, these factors are not
shown. The complex scans the mRNA for the start codon. During this time, GTP bound to eIF2 can be hydro- tion of eIF1 decreases the amount of
lyzed with the help of eIF5, but this reaction is reversible because phosphate is not released. During the GTP hydrolysis observed in the
scanning process, the PIC is in an open state, which is in equilibrium with a closed state that is not capable of
scanning but is able to investigate the codon in the P-site. In this figure, the closed state is represented by a lock, absence of mRNA. In the presence of
holding the mRNA in place. When an AUG codon is identified in the P-site, the equilibrium shifts toward the cap-bound eIF4F and eIF1, eIF1A,
closed state. eIF1 dissociates from the 40 S ribosome, and the phosphate ion bound to eIF2 can now be and eIF3, hydrolysis in the absence of
released, making hydrolysis irreversible and committing the PIC to initiate translation at the codon currently in
the P-site. After dissociation from the ribosome, eIF1 may remain bound to the PIC through an interaction with a start codon is reduced by 80% (21).
eIF3 (29). After eIF2䡠GDP and eIF5 dissociate, the 60 S subunit joins the 40 S subunit with the help of the GTPase Phosphate release was later identified
eIF5B. The 80 S initiation complex is now ready to begin the elongation phase of translation. Factors in this
as the point at which eIF1 inhibits
figure are not drawn to scale to make the smaller factors visible.
overall GTP hydrolysis prior to start
codon recognition (4).
The importance of both factors in start codon selection was
intimately linked, and this review will focus on the workings of
indicated by primer extension (“toeprinting”) studies, which
these proteins in this key step in genetic decoding.
allow the positions of PICs on mRNAs to be determined. These
Searching for the Start Codon
experiments revealed that in the absence of both eIF1 and
One of the first functions attributed to eIF1 and eIF1A was eIF1A, the 40 S subunit is located very close to the 5⬘-cap of the
facilitating TC binding to the 40 S ribosome (8 –13). In addition mRNA and is unable to locate the start codon. The addition of
to assisting TC recruitment, eIF1 and eIF1A facilitate recruit- eIF1 removes these complexes, but eIF1A is required for the
ment of one another by binding cooperatively to the 40 S sub- proper start codon to be found (22). This result is consistent
unit (14). eIF1A was also shown to have other functions that with eIF1 acting as a negative regulator of incorrectly located
promote the formation of PICs, including dissociating 40 S PICs and with eIF1A acting to stabilize properly formed complexes. Primer extension studies also showed that complexes
dimers (15) and recruiting mRNA (8).
Early genetic work identified eIF1 as an essential player in start can form at the near-cognate AUU codon in the absence of eIF1
codon recognition (16, 17). A screen for suppressors of a mutation (23), further indicating that eIF1 is involved in distinguishing
in the start codon of the HIS4 gene identified mutations in eIF1 between cognate and near-cognate start codons. Both eIF1 and
that produced a Sui⫺ (suppressor of initiation codon mutations) eIF1A also help differentiate between start codons in a “good”
phenotype (17). These mutations allow initiation to occur at an context, i.e. the Kozak consensus sequence surrounding many
5
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FIGURE 2. NMR structures of eIF1 and eIF1A. a, the solution structure of
human eIF1 (36) is represented in rainbow coloring, from red at the C terminus to blue at the N terminus. The ensemble of structures consistent with the
NMR data is overlaid to accentuate the unstructured nature of the N-terminal
tail. b, the solution structure of human eIF1A (44) is represented as described
for a. Note that both the N- and C-terminal regions of eIF1A are unstructured.

start codons in mammals (5), and a “bad” context. In the
absence of eIF1A, PICs are able to scan through good context
AUG codons, and in the absence of eIF1, a PIC is more likely to
stop at an AUG codon in a bad context, consistent with roles as
positive and negative regulators of start codon recognition,
respectively (23). The authors of this work speculated that the
two factors might influence the equilibrium of the PIC between
two states. In one state, which they called the “open” state, the
complex is able to scan the mRNA, and base pairing with the
tRNA cannot occur. In the other conformation, the “closed”
state, the complex can no longer scan the mRNA, and the tRNA
is able to interact with the P-site codon. The existence of such
an equilibrium has been supported by a growing body of
genetic, biochemical, and structural data.
Kinetic studies of the stability of eIF1A in PICs, which probe
the strength of interactions between the factor and other components in the complex, provided the first evidence that two
types of complexes exist and that eIF1A plays a key role in
determining the balance between the two (24). In the presence
of both eIF5 and an AUG codon, the equilibrium between these
two states is shifted toward the one in which eIF1A makes more
favorable interactions. Mutations in both eIF1A and eIF5 that
increase initiation at non-AUG codons in vivo strengthen this
shift in the presence of a UUG codon and weaken it in the
presence of an AUG codon. In addition, mutants of eIF1A that
have a leaky scanning phenotype strongly shift the equilibrium
toward the state in which eIF1A makes fewer stabilizing interactions (25). When eIF1A is bound more tightly, a reduction in
OCTOBER 10, 2008 • VOLUME 283 • NUMBER 41

the conformational freedom of its C terminus is also observed,
indicating that a structural change has taken place in which this
region has become more confined (24, 25). These data are consistent with a model in which the more tightly bound state is the
closed one and the less tightly bound state is the open, scanning-competent complex.
Primer extension studies also support a role for eIF1A in
maintaining this equilibrium. A mutation in eIF1A leads to the
formation of a PIC that stalls on the mRNA between the 5⬘-cap
and the start codon (19). This error is thought to be due to a
scanning defect, consistent with a role for eIF1A in maintaining
an open, scanning-competent complex.
Recent structural studies may have actually captured pictures of the open and closed states. Cryoelectron microscopy
(cryo-EM) reconstructions of the yeast 40 S ribosomal subunit
alone and with eIF1 and/or eIF1A bound demonstrate that
these factors alter the accessibility of the mRNA binding channel. When both factors are bound, the “latch” region of the
channel is no longer visible, and a new connection is formed
between the head and shoulder on the back side of the subunit
(26). This conformation would likely promote mRNA binding
and allow the ribosome to move more easily across the mRNA.
A similar result was achieved in a cryo-EM reconstruction of
the 40 S subunit bound to eIF1A and the multifactor complex
(MFC), which is composed of eIF1, eIF3, eIF5, and TC (27).
These results are consistent with earlier hydroxyl radical cleavage
studies that suggested that structural changes occur in the mRNA
binding region of the ribosome upon association of eIF1 (28).
The unstructured N and C termini of eIF1A have been identified as particularly important for proper maintenance of the
equilibrium between the open and closed states. Interestingly,
the two termini take on opposite roles, with mutations in the
N-terminal tail (NTT) causing leaky scanning phenotypes and
acting as suppressors of Sui⫺ mutations and with mutations in
the C-terminal tail (CTT) producing Sui⫺ phenotypes (19, 25).
Like a molecular version of Dr. Doolittle’s two-headed pushmipullyu, the ends of eIF1A are moving toward opposing goals,
but instead of reaching a stalemate, the factor is able to walk the
fine line between moving past near-cognate codons and identifying the subtly different cognate start codon.

Response to Start Codon Recognition
Once the start codon has finally been found, how does translation initiation proceed if eIF1 is preventing conversion of
GTP to GDP and subsequent commitment of the complex?
Fluorescence resonance energy transfer-based studies revealed
that a conformational change takes place in the PIC upon start
codon recognition, causing the C termini of eIF1 and eIF1A to
move away from each other (29). This conformational change is
followed by dissociation of eIF1 from the complex, which in
turn allows phosphate release to occur (4, 29). eIF2䡠GDP, most
likely in complex with eIF5, can then dissociate from the PIC,
which allows downstream events to proceed.
Recent in vivo and in vitro data have substantiated the importance of eIF1 release by demonstrating that mutations in eIF1
that produce Sui⫺ phenotypes lower the affinity of the factor for
the 40 S subunit, cause it to dissociate more easily, and lead to
an increased rate of Pi release (30). These Sui⫺ phenotypes can
JOURNAL OF BIOLOGICAL CHEMISTRY

27347

MINIREVIEW: eIF1 and eIF1A Control Start Codon Recognition
be reduced by overexpression of the mutant factors presumably
because mass action causes an increase in PIC-bound eIF1 (30).
Structural data also support the proposal that the PIC rearranges to the closed state after eIF1 dissociation. Cryo-EM
reconstructions of the 40 S complexes revealed that eIF1 and
eIF1A synergistically induce the open conformation and that
neither alone is able to produce this state. In fact, in the 40 S
subunit䡠eIF1A complex, there is actually an increase in the density of the latch of the mRNA binding channel compared with
the unoccupied 40 S subunit, suggesting that this complex is
even more closed than the naked subunit (26). Release of eIF1
after start codon recognition would leave eIF1A alone in the
PIC, and based on these cryo-EM data, it would be unable to
stabilize the open state of the complex, causing it to revert to the
closed, scanning-arrested form.
From the description above, it would seem as if eIF1 were the
key player in start site selection and eIF1A an overeager factor
that must be restrained until the proper moment, but this
would be too harsh a judgment of eIF1A. In fact, eIF1A seems to
be intimately involved in giving eIF1 permission to leave its
post. NTT mutations in eIF1A that suppress the Sui⫺ phenotypes of mutations in other factors slow both the conformational change that occurs upon start codon recognition and the
subsequent release of eIF1 (30). The sum of the data presented
here and above suggests that an increase in stabilizing interactions
between eIF1A and the PIC is a key step in start codon recognition
that is likely required for efficient eIF1 release (29, 30).

Factor Interactions
Just as for the termini of eIF1A, the two ends of eIF1 play
important roles in the events surrounding start codon recognition. The ability of eIF1 to promote MFC binding to the ribosome is mediated through its two ends. The presence of a FLAG
tag at either end reduces binding of the factor to eIF3 and the 40
S subunit and eliminates its ability to bind to eIF2 and eIF5 (31),
and mutations in both the N and C termini have been found to
reduce the efficiency of PIC formation in vivo and in vitro (30).
Because of the unstructured nature of both the CTT and NTT
of eIF1A and the NTT of eIF1, these regions have a large degree
of conformational flexibility, potentially allowing them to interact with a variety of other factors during translation initiation. It
is likely that the unstructured nature of the termini of eIF1 and
eIF1A increases their reach both physically across the ribosome
and functionally throughout the initiation pathway. The terminal regions are not conserved in the bacterial ortholog of eIF1A,
IF1, suggesting that they play roles specific to eukaryotic translation, consistent with their abilities to interact with factors
without bacterial counterparts (eIF2, eIF3, and eIF5).
The CTT of eIF1A promotes MFC recruitment to the 40 S
subunit, whereas the NTT, which also interacts with components of the MFC, is not necessary for recruitment of these
factors to the PIC (19). This discrepancy suggests that the NTT
interactions might be necessary at a later step of translation
initiation such as scanning or start codon identification (32).
Based on these observations, it was suggested that eIF1A has a
modular structure, in which the central OB-fold serves as a 40 S
binding domain, whereas the termini are able to interact with a
variety of factors. Considering that the termini of eIF1 and
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eIF1A are involved in both start site selection and protein-protein interactions, these interactions may be key for transfer of
the “go” signal from the start codon to the factors responsible
for GTP hydrolysis. Prior to start codon recognition, eIF1 and
eIF1A interact on the 40 S subunit (14). After start codon recognition, eIF1 is released, and eIF1A interacts, either directly or
indirectly, with eIF5 (29). One appealing but unproved possibility is that when eIF1 is ejected from the PIC, breaking its
interaction with eIF1A, eIF1A is freed to interact with eIF5, and
this new interaction is involved in triggering Pi release from
eIF2. An arginine in the N terminus of eIF5 has been proposed
to act as an arginine finger to activate GTP hydrolysis by eIF2
(33, 34), and thus, it seems possible that eIF5 might hinder Pi
release by virtue of its binding in the GTPase active site and that
the interaction with eIF1A might cause it to alter position or
conformation enough to allow Pi to dissociate.
It has been suggested that eIF1 may also serve as a link
between the start codon and eIF5 (35). NMR studies have
shown an interaction between eIF5 and eIF1 at the latter’s NTT
and a region composed of basic and hydrophobic residues. The
direct interaction between eIF1 and eIF5 is not observed under
all conditions (35, 36), but the two may be in close proximity on
the PIC. Both bind to eIF3c in the MFC, which could promote a
direct or indirect interaction. Although most of the body of eIF3
is located on the solvent-exposed side of the 40 S subunit (37,
38), whereas the factors are bound to the interface side, an unidentified portion of eIF3 has been shown to reach around
toward the intersubunit face where it might be close enough to
interact with eIF1 or eIF5 (37). Mutations in eIF3 with Sui⫺ and
suppressor of Sui⫺ phenotypes suggest that this factor also
plays a role in start site selection (18).
A competitive interaction between eIF1 and eIF5 for eIF2 has
also been suggested because of structural similarity between the
N-terminal domain (NTD) of eIF5 and factors eIF1 and eIF2␤
(39). This finding led the authors to suggest that these three
protein domains compete for binding to eIF2␥. Their model
suggests that eIF1 interacts with eIF2␥, preventing eIF5-stimulated GTP hydrolysis until the MFC binds the 40 S ribosome, at
which point the eIF5 NTD replaces eIF1 in interacting with
eIF2␥, promoting reversible GTP hydrolysis. After start codon
selection and GTP hydrolysis, eIF2␤ could take the place of the
eIF5 NTD, helping eIF2 to dissociate from the PIC. Moving
eIF5 away from the GTPase center of eIF2 could also serve to
remove a physical barrier for Pi, allowing Pi release upon start
codon recognition. This change of binding partners could be
promoted by the interaction between eIF1A and eIF5.
eIF1 is not the only factor with a competitive spirit. Directed
hydroxyl radical probing showed that eIF3j, a loosely bound
subunit of eIF3, binds to the mRNA binding channel and the A-site
of the ribosome. eIF3j displays negative cooperativity with eIF1A
and, in the absence of TC, with mRNA in binding the 40 S subunit
(40). The consequences of this competition are not yet fully understood, but because eIF3j is not an essential protein in yeast, it may
be that this interaction is required only for the translation of select
mRNAs or for fine-tuning of the process.
If these possible interactions are not enough to make your
head spin, another factor has been thrown into the equation.
eIF4G, part of the eIF4F 5⬘-cap binding complex, has been
VOLUME 283 • NUMBER 41 • OCTOBER 10, 2008
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shown to interact with both eIF1 and eIF5 (41, 42). The observation that a mutation in eIF1 that produces a Sui⫺ phenotype
in vivo reduces this interaction with eIF4G led to the suggestion
that eIF4G may influence scanning and start codon selection
through eIF1 (42).
The pathway of communication between the start codon and
the GTPase active site of eIF2 has not yet been fully defined, but
the number of proposed interactions rivals those seen in the
most complex of biological systems. It is unlikely that all of
these connections are important in vivo. Defining those that are
necessary for start site selection is a key step in the development
of a molecular mechanism of translation initiation. eIF5 is
emerging as the center of this tangled web of interactions. Elucidating its binding partners throughout the process of initiation would be of great interest.

Conclusions
In the past decade, a growing body of biochemical and biophysical data has added to the genetic observations that first
identified eIF1 and eIF1A as regulators of start site selection.
These data have elucidated the role of eIF1 as a negative regulator of phosphate release that is ejected from the PIC upon
start codon recognition and revealed the complex balance that
eIF1A strikes in promoting both scanning and start site selection, ultimately interacting more strongly with the PIC upon
start codon recognition and stabilizing the closed state of the
complex. Such advances could not have been made without
combining the power of genetic studies with the detail of biochemical and biophysical work.
A recent genetic study on the roles played by eIF3 and eIF4G
in mRNA recruitment and scanning suggests that eIF4G plays a
role after mRNA binding (43), contrary to the accepted view
that its primary function is as a scaffolding protein required for
mRNA recruitment. It will not be long before the same combination of genetic, biochemical, and structural studies will elucidate the roles of eIF4G and eIF3 as well as those of the many
other factors more poorly understood than eIF1 and eIF1A.
Such studies may also increase our understanding of the “black
box” of the current model, scanning. A full understanding of the
molecular mechanics of start codon recognition will not be possible without a detailed dissection of this key process.
Acknowledgments—We thank Alan Hinnebusch, Sarah Kolitz, and
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